Question · asked by 1 review
Immunoglobulin vs placebo: Length of hospitalisation (days)
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Summary of findings table ‐ Immunoglobulins vs placebo Length of hospitalisation (days) · children with respiratory syncytial virus infection Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus… (2023) · Cochrane Headline outcomes only | no estimate extracted | 6 studies · 737 participants | Moderate |
Immunoglobulins vs placebo Length of hospitalisation (days) · children with respiratory syncytial virus infection Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus… (2019) · Cochrane Headline outcomes onlyearlier version CD009417.PUB2, superseded | no estimate extracted | 5 studies · 324 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection 2023 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.